NEW YORK (GenomeWeb News) — The National Heart Lung and Blood Institute today said it is seeking partners to work with its Framingham Heart Study to create a biomarker consortium that will research markers associated with cardiovascular disease.
 
The initiative, which aims to develop new diagnostics that can identify high-risk individuals, will also focus on CVD-related risk factors such as atherosclerosis, obesity, insulin resistance, hypertension, and metabolic syndrome.
   

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.